Cumulative Real-World Experience with Deutetrabenazine for Huntington’s Disease Chorea at a Single Center of Excellence in the US
Objective: To summarize clinical experience and outcomes with deutetrabenazine (DTBZ) as a treatment for Huntington’s disease (HD) chorea from the Huntington’s Disease Society of America…Characterizing Racial and Ethnic Diversity Among Enroll-HD Participants in the US and Canada
Objective: To characterize racial and ethnic diversity among Huntington’s disease (HD) gene expansion carriers (GECs) in the Enroll-HD study in the US and Canada. Background:…Impaired saccadic inhibition in Huntington mutation carriers
Objective: To assess saccadic paradigms in asymptomatic Huntington disease mutation carriers. Background: Huntington’s disease (HD) is characterized by motor, cognitive and behavioural abnormalities, such as…Brain MRI Cortical Atrophy correlation to clinical onset in Huntington’s Disease
Objective: To describe brain Magnetic Resonance Imaging (MRI) characteristics in Latin American individuals with Huntington's Disease (HD) and to correlate them to major symptom at…Evolving inclusion criteria in early manifest Huntington’s disease (HD) to address striatal atrophy: Lessons from HD-GeneTRX-1, the first gene therapy trial
Objective: To describe the early screening experience and evidence-based adaptations to the inclusion criteria for HD-GeneTRX-1 (NCT04120493). Background: AMT-130 is an AAV5-based gene therapy intended…Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease
Objective: Proof-of-concept phase IIa study assessing bevantolol (SOM3355) efficacy and safety in reducing chorea in Huntington’s disease (HD). Background: Bevantolol hydrochloride, a β1‐adrenoceptor antagonist used…Extending the spectrum of non-motor symptoms in pre-motor Huntington’s disease – a pilot study
Objective: The aim of this pilot study was to investigate change of olfactory functions in Huntington's disease. Background: Huntington's disease (HD) is a neurodegenerative disease…Genetic features and long-term outcome of Korean patients with Huntington’s disease.
Objective: To investigate the genetic characteristics and long-term outcome of Korean patients with Huntington’s disease. Background: Huntington’s disease is an autosomal dominant neurodegenerative disease, which…Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD
Objective: We describe a case of Huntington’s disease (HD) associated chorea and concurrent functional movement disorder (FMD). Background: HD is a neurodegenerative disorder characterized by…A screening tool to assess telehealth suitability among patients with Huntington’s disease
Objective: To evaluate a screening tool to assess telehealth (TH) suitability among Huntington’s disease (HD) patients Background: Extenuating patient circumstances [1] and COVID-19 necessitate greater…
- « Previous Page
- 1
- …
- 718
- 719
- 720
- 721
- 722
- …
- 1734
- Next Page »